HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Raises Price Target to $28
Benzinga Newsdesk 9 hours ago
Analyst RatingsNewsPrice Target
HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $25 to $28.
HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $25 to $28.